Cargando…
Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19
Patients with underlying diseases and coronavirus disease 2019 (COVID-19) are at increased risk of death. Using the recommended anti-COVID-19 drug, chloroquine phosphate (CQ), to treat patients with severe cases and type 2 diabetes (T2D) could potentially cause harm. We aimed to understand the safet...
Autores principales: | Gao, Xiuge, Jing, Xian, Wang, Junqi, Zheng, Yuling, Qiu, Yawei, Ji, Hui, Peng, Lin, Jiang, Shanxiang, Wu, Wenda, Guo, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023373/ https://www.ncbi.nlm.nih.gov/pubmed/35469826 http://dx.doi.org/10.1016/j.cbi.2022.109954 |
Ejemplares similares
-
Hypertension related toxicity of chloroquine explains its failure against COVID-19: Based on rat model
por: Wang, Junqi, et al.
Publicado: (2022) -
Development and Validation of an Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry Method to Determine Maduramicin in Crayfish (Procambarus clarkii) and Evaluate Food Safety
por: Gao, Xiuge, et al.
Publicado: (2021) -
Ionophore Toxin Maduramicin Produces Haff Disease-Like Rhabdomyolysis in a Mouse Model
por: Gao, Xiuge, et al.
Publicado: (2020) -
Preparation and in vitro release kinetics of ivermectin sustained-release bolus optimized by response surface methodology
por: Ruan, Xiangchun, et al.
Publicado: (2018) -
Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine
por: Gao, Ying, et al.
Publicado: (2020)